Michael Walters, a 24-year-old from Auckland, New Zealand, is facing a daunting challenge as he battles aggressive non-Hodgkin’s lymphoma. Initially set to receive cutting-edge CAR-T cell therapy through a clinical trial in New Zealand, he was disqualified when his condition deteriorated too quickly. In response to his situation, supporters have raised over $264,000 towards the estimated $500,000 required for treatment abroad, potentially in Australia or China. Walters, who was diagnosed in April 2025, had just begun his career as a property manager and was actively engaged in his social life and fitness. The Cancer Society has highlighted the financial burden that such treatments impose on families, noting that costs can range from $500,000 to $1 million, which adds to the stress of dealing with a cancer diagnosis. As Walters prepares for this critical journey, the support from his community reflects the urgent need for accessible and affordable cancer treatment options.